Home       Market Dynamics     Sector Analysis     Company Insights     AI Investing     Strategies     Contact Us     Login             

Alnylam Pharmaceuticals (ALNY) Stock Price Prediction and News Highlight
Mon. Nov 10, 2025

Recent advancements in RNAi therapeutics, particularly through the use of vutrisiran, have significantly enhanced the treatment landscape for patients with ATTR-CM. The emergence of new treatment options has positively impacted patient care, providing hope for better management of this condition. These developments reflect a strong sentiment towards innovation in therapeutic applications, marking a pivotal shift in how ATTR-CM is approached. Such advancements not only emphasize the efficacy of new treatments but also highlight the growing focus on patient-centric approaches in pharmaceuticals.

The price action of Alnylam Pharmaceuticals (ALNY) is impacted by broad market risk appetite, sector price trend, company-specific performance and market structure. The market sentiment at 0.2 is modestly bullish. Trend sentiment measures the current trend of the stock price, and market sentiment reflects what market participants collectively think where the price will move next.There is no clear direction for ALNY since trend sentiment and market sentiment are at the opposite directions. The positive sentiment force for sector is at 0.4, and the negative at -0.2 on 2025-11-10. The forces of and Valuation Sentiment (-1) will drive down the price. The forces of Stock Price Trend (0), Sector Price Trend (0), Price Level Sentiment (0), Option Sentiment (0), Market Risk Appetite (0), and Sentiment towards Fundamentals (2.3) will drive up the price.

The sentiment for Sector Price Trend is calculated based on the price trend of related sector ETF. The sentiment for Option Speculation is calculated from put/call ratio. The Risk Appetite is calculated from Bitcoin price trend. Price Level sentiment is positive when oversold, and negative when overbought. Valuation Sentiment, and Sentimentals towards Fundamentals are extracted from headlines and market commentary. All sentiment scores are normalized on a -10 - +10 scale. The price level reaches 100 at Bollinger upper band, and zero at lower band.

Earning Release: 2026-02-11 10:00, EPS: $0.31, P/E: 1426

ALNY
DateAttentionPricePrice
Level
ChangeSMA10
Trend
Trend
Sentiment
Hourly
Trend
Hourly
StdDev
Market
Sentiment
ActionPFund.News
Sentiment
2025-11-100%(0%)    0    0%    0.2          2.3    -1   
2025-11-090%(0%)    0    0%    0          1.1    -1   
2025-11-080%(0%)    0    0%    -0.3          -0.5    -1   
2025-11-070%(0%)    0    0%    -0.3          -0.5    -1   
2025-11-060%(0%)    0    0%    -0.1          0.7    -1   
2025-11-050%(0%)    0    0%    -0          0.9    -1   
2025-11-040%(0%)    0    0%    -0.1          0.5    -1   
2025-11-030%(0%)    0    0%    0.1          1.7    -1   
2025-11-020%(0%)    0    0%    0.3          3    -1   
2025-11-010%(0%)    0    0%    0.3          3    -1   
 
Wait action is recommended in three scenarios with either high uncertainty or high risk: 1. The trend sentiment and market sentiment are at the opposite directions. 2. Both trend sentiment and market sentiment are positive, but the price level is elevated. 3. Both trend sentiment and market sentiment are negative, but the price level is depressed. In an uptrend, as an investor, you may want to wait for the pullback to open long position. In a downtrend, the price will likely rebound after huge decline. As an investor, you may want to wait for the rebound to exit long position.
Market sentiment will accelerate the current trend when both trend sentiment and market sentiment are at the same direction. Market sentiment will generate volatility when it's at the opposite direction of the trend sentiment. News sentiment measures the daily emotion of the market. News sentiment may impact the daily price change while market sentiment is a more stable and consistent moving force.

2025-11-10 17:10:19 Alnylam's strategies may include partnerships and investments, which could enhance its market position.
2025-11-10 17:10:19 Potential regulatory changes in the healthcare sector may affect Alnylam's operational landscape.
2025-11-10 17:10:19 Emerging trends in the healthcare industry highlighted during conferences may positively impact future company direction.
2025-11-10 17:10:19 The presence of key executives at major conferences suggests strong leadership, contributing to positive investor sentiment.
2025-11-10 17:10:19 The performance of Alnylam Pharmaceuticals' stock has shown minor declines, indicating fluctuations in investor confidence.


About   Contact Us  
Copyright ©2025 TheMarketUnfolds. All rights reserved. Denver, Colorado, USA